In the field of inflammation/infection imaging, nuclear medicine techniques offer non-invasive tools to detect early pathophysiological changes before the development of anatomical changes detected by radiological procedures and, often, before clinical onset of symptoms. This field has been recently developed with several new radiopharmaceuticals for SPECT and PET used to define new strategies for imaging immune cells as well as pathogens.In particular, we count now several dozens of new radiopharmaceuticals designed for bacterial imaging and new peptides and antibodies for imaging neutrophils, T-cells, B-cells and macrophages.These may have important applications not only for diagnostic purposes but also for prognostic purposes, therapy decision making and for early follow-up of therapy efficacy, thus allowing us to define specific therapies for each individual patient.

Editorial. Molecular Imaging of Inflammation/Infection. The Future of Disease Management / Signore, A.; Erba, P. A.. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1873-4286. - 24:7(2018), pp. 741-742. [10.2174/138161282407180514095417]

Editorial. Molecular Imaging of Inflammation/Infection. The Future of Disease Management

Signore A.;
2018

Abstract

In the field of inflammation/infection imaging, nuclear medicine techniques offer non-invasive tools to detect early pathophysiological changes before the development of anatomical changes detected by radiological procedures and, often, before clinical onset of symptoms. This field has been recently developed with several new radiopharmaceuticals for SPECT and PET used to define new strategies for imaging immune cells as well as pathogens.In particular, we count now several dozens of new radiopharmaceuticals designed for bacterial imaging and new peptides and antibodies for imaging neutrophils, T-cells, B-cells and macrophages.These may have important applications not only for diagnostic purposes but also for prognostic purposes, therapy decision making and for early follow-up of therapy efficacy, thus allowing us to define specific therapies for each individual patient.
2018
communicable diseases; fluorodeoxyglucose f18; humans; inflammation; molecular imaging; nuclear medicine; positron emission tomography computed tomography
01 Pubblicazione su rivista::01m Editorial/Introduzione in rivista
Editorial. Molecular Imaging of Inflammation/Infection. The Future of Disease Management / Signore, A.; Erba, P. A.. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1873-4286. - 24:7(2018), pp. 741-742. [10.2174/138161282407180514095417]
File allegati a questo prodotto
File Dimensione Formato  
Signore_Molecular-Imaging_2018.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 908.18 kB
Formato Adobe PDF
908.18 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1413614
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact